National Comprehensive Cancer Network



About NCCN

Melanoma Panel - Disclosures as of 5/4/2012

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support Advisory Boards, Speakers Bureau, Expert Witness, or Consultant Patent, Equity, or Royalty Other Date Completed

Robert Andtbacka, MD

None

None

None

None

4/23/2012

Christopher J. Anker, MD

None

None

None

None

3/1/2013

Christopher K. Bichakjian, MD

None

None

None

None

10/17/2012

William E. Carson III, MD

None

None

None

None

4/6/2013

Daniel G. Coit, MD

None

None

None

None

3/9/2013

Adil Daud, MD

Abbott Laboratories;
GlaxoSmithKline;
Merck & Co., Inc.;
Pfizer Inc.;
Roche Laboratories, Inc.;
Schering-Plough Corporation;
Wyeth Pharmaceuticals

Bristol-Myers Squibb Company;
Merck & Co., Inc.

None

None

12/12/2011

Dominick DiMaio, MD

None

None

None

None

3/3/2013

Martin D. Fleming, MD, FACS

None

None

None

None

4/4/2013

Lauren Gallagher, RPh, PhD

None

None

None

None

6/18/2013

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

10/23/2012

Valerie Guild

None

None

None

None

4/8/2013

Allan C. Halpern, MD

Quintiles

None

None

None

3/1/2013

Maria Ho, PhD

None

None

None

None

8/3/2012

F. Stephen Hodi, MD

None

Bristol-Myers Squibb Company;
MedImmune Inc.;
Novartis Pharmaceuticals Corporation

None

None

4/4/2013

Mark C. Kelley, MD, MMHC, FACS

None

None

None

None

10/7/2012

Nikhil I. Khushalani, MD

None

Prometheus

None

None

5/3/2013

Ragini R. Kudchadkar, MD

None

Genentech, Inc.

None

None

5/16/2012

Julie R. Lange, MD, ScM

None

None

None

None

3/24/2013

Anne Lind, MD

None

None

None

None

4/20/2012

Mary C. Martini, MD

Electro-Optical Sciences Inc

dove- unilever

None

None

4/7/2013

Joan S. McClure, MS

None

None

None

None

7/23/2012

Nicole McMillian, MS

None

None

None

None

3/27/2013

Anthony J. Olszanski, MD

None

None

None

None

4/4/2013

Scott K. Pruitt, MD, PhD

None

None

None

None

8/12/2012

Merrick I. Ross, MD

None

Genentech, Inc.;
Schering-Plough Corporation

None

None

8/10/2012

Susan M. Swetter, MD

None

None

None

None

2/28/2013

Kenneth K. Tanabe, MD

None

None

None

None

10/3/2012

John A. Thompson, MD

Bristol-Myers Squibb Company;
Genentech, Inc.;
GlaxoSmithKline;
ImClone Systems Incorporated;
Novartis Pharmaceuticals Corporation;
Altor Biosciences

Bristol-Myers Squibb Company

None

None

7/13/2012

Vijay Trisal, MD

None

None

None

None

6/2/2011

Marshall M. Urist, MD

None

None

None

None

5/2/2013

 

About NCCN| NCCN Member Institutions| Patient Resources| NCCN Foundation| Privacy Policy| Legal Notices| Contact Us

275 Commerce Drive, Suite 300, Fort Washington, PA 19034 • 215.690.0300 • Fax: 215.690.0260
Copyright © 2012 National Comprehensive Cancer Network, All Rights Reserved